Gaudium IVF IPO is to open on February 20, 2026. It is a Mainboard IPO that will raise â‚ą165 crores. The Gaudium IVF IPO price band is fixed at â‚ą75 to â‚ą79 with a market lot of 189 Shares.
Gaudium IVF IPO GMP Live Rates day by day with Kostak rates.
| Date | IPO GMP | GMP Trend | Gain |
| 27 Feb | â‚ą-4 |  | -5.06% |
| 26 Feb | â‚ą-4 | | -5.06% |
| 25 Feb | â‚ą- | – | -% |
| 24 Feb | â‚ą5 | | 6.33% |
| 23 Feb | â‚ą8.5 |  | 10.76% |
| 21 Feb | â‚ą8 | | 10.53% |
| 20 Feb | â‚ą8 | | 10.53% |
| 19 Feb | â‚ą10 | | 12.66% |
| 18 Feb | â‚ą10 | | 12.66% |
| 17 Feb | â‚ą10 | | 12.66% |
| 16 Feb | â‚ą- | – | -% |
| 14 Feb | â‚ą- | – | -% |
| 13 Feb | â‚ą- | – | -% |
Gaudium IVF IPO Details
| IPO Open Date | February 20, 2026 |
| IPO Close Date | February 24, 2026 |
| Face Value | â‚ą5 Per Equity Share |
| IPO Price Band | â‚ą75 to â‚ą79 Per Share |
| Issue Size | Approx â‚ą165 Crores |
| Fresh Issue | Approx â‚ą90 Crores |
| Offer for Sale: | Approx 94,93,700 Equity Shares |
| Issue Type | Book build Issue |
| IPO Listing | BSE, NSE |
| DRHP Draft Prospectus |  |
| RHP Draft Prospectus | |
Gaudium IVF IPO Dates
| IPO Open Date: | February 20, 2026 |
| IPO Close Date: | February 24, 2026 |
| Basis of Allotment: | February 25, 2026 |
| Refunds: | February 26, 2026 |
| Credit to Demat Account: | February 26, 2026 |
| IPO Listing Date: | February 27, 2026 |
| IPO Bidding Cut-off Time: | February 24, 2026 – 5 PM |
Business Overview
Gaudium IVF, founded in March 2015, is one of the leading companies offering In Vitro Fertilization (IVF) treatments for women across India. The company operates its business over 30 locations, with seven hubs (centres) and twenty-eight spokes. The firm treats its patients in various countries, including Canada, the United Kingdom, the United States, Kenya, South Africa, and Oman.
The firm offers various fertility services such as Vitro Fertilisation (IVF), intracytoplasmic sperm injection (ICSI), intrauterine insemination (IUI), and ovulation induction. Its treatments are targeted towards both genders. Moreover, the firm also provides PCOD/PCOS, endometriosis, and special care for women in pregnancy with complex fertility issues. Gaudium IVF also offers treatments targeting male infertility, including advanced sperm retrieval procedures.
Gaudium IVF IPO GMP aka Grey Market Premium FAQs:
What is Gaudium IVF IPO GMP Today?
What is Gaudium IVF IPO Expected Returns?
Disclaimer:
- IPO Grey Market Premium (Gaudium IVF IPO GMP) mention is valid for the specific date as mentioned in the header.
- We are not buying and selling IPO forms on IPO Grey Market.
- Kostak Rate is the premium one gets by selling his/her IPO application (in an off-market transaction) to someone else even before allotment or listing of the issue.
- Do not subscribe for IPO by just seeing the premium Price as it may change anytime before listing. Subscribe only considering the fundamentals of the companies.
One Response
Not researched well. This is a fraud company